1381 related articles for article (PubMed ID: 16952214)
21. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
[TBL] [Abstract][Full Text] [Related]
22. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
23. Does vaginal bleeding influence first-trimester markers for Down syndrome?
Heinig J; Steinhard J; Schmitz R; Nofer JR; Witteler R; Mosel A; Ahrens A; Kiesel L; Klockenbusch W
Prenat Diagn; 2007 Apr; 27(4):312-6. PubMed ID: 17286311
[TBL] [Abstract][Full Text] [Related]
24. The effect of Rhesus status on first-trimester pregnancy screening markers free beta human chorionic gonadotropin, pregnancy-associated plasma protein-A and nuchal translucency.
Cowans NJ; Stamatopoulou A; Spencer K
Prenat Diagn; 2009 May; 29(5):505-7. PubMed ID: 19222026
[TBL] [Abstract][Full Text] [Related]
25. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers.
Spencer K; Kagan KO; Nicolaides KH
Prenat Diagn; 2008 Jan; 28(1):49-52. PubMed ID: 18186136
[TBL] [Abstract][Full Text] [Related]
26. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
Maiz N; Valencia C; Emmanuel EE; Staboulidou I; Nicolaides KH
Obstet Gynecol; 2008 Sep; 112(3):598-605. PubMed ID: 18757658
[TBL] [Abstract][Full Text] [Related]
27. Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11-13+6 weeks of gestation.
Kagan KO; Frisova V; Nicolaides KH; Spencer K
Prenat Diagn; 2007 Sep; 27(9):849-53. PubMed ID: 17590888
[TBL] [Abstract][Full Text] [Related]
28. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program.
Krantz DA; Hallahan TW; Macri VJ; Macri JN
Prenat Diagn; 2005 Aug; 25(8):635-40. PubMed ID: 16049986
[TBL] [Abstract][Full Text] [Related]
29. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Valencia C; Maiz N; Nicolaides KH
Hum Reprod; 2008 Sep; 23(9):1968-75. PubMed ID: 18544579
[TBL] [Abstract][Full Text] [Related]
30. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
Dugoff L; Hobbins JC; Malone FD; Porter TF; Luthy D; Comstock CH; Hankins G; Berkowitz RL; Merkatz I; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Vidaver J; D'Alton ME
Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981
[TBL] [Abstract][Full Text] [Related]
31. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception.
Tul N; Novak-Antolic Z
Prenat Diagn; 2006 Dec; 26(13):1206-11. PubMed ID: 17075793
[TBL] [Abstract][Full Text] [Related]
32. The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy.
Spencer K; Cicero S; Atzei A; Otigbah C; Nicolaides KH
Prenat Diagn; 2005 Oct; 25(10):927-9. PubMed ID: 16088864
[TBL] [Abstract][Full Text] [Related]
33. Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation.
Kagan KO; Anderson JM; Anwandter G; Neksasova K; Nicolaides KH
Prenat Diagn; 2008 Dec; 28(13):1209-13. PubMed ID: 19039823
[TBL] [Abstract][Full Text] [Related]
34. Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester.
Spencer K; Liao AW; Ong CY; Geerts L; Nicolaides KH
Prenat Diagn; 2001 Jun; 21(6):441-4. PubMed ID: 11438945
[TBL] [Abstract][Full Text] [Related]
35. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
Soergel P; Pruggmayer M; Schwerdtfeger R; Muhlhaus K; Scharf A
Fetal Diagn Ther; 2006; 21(3):264-8. PubMed ID: 16601335
[TBL] [Abstract][Full Text] [Related]
36. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome.
Yaron Y; Heifetz S; Ochshorn Y; Lehavi O; Orr-Urtreger A
Prenat Diagn; 2002 Sep; 22(9):778-82. PubMed ID: 12224070
[TBL] [Abstract][Full Text] [Related]
37. Which ultrasound or biochemical markers are independent predictors of small-for-gestational age?
Law LW; Leung TY; Sahota DS; Chan LW; Fung TY; Lau TK
Ultrasound Obstet Gynecol; 2009 Sep; 34(3):283-7. PubMed ID: 19670336
[TBL] [Abstract][Full Text] [Related]
38. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation.
Wright D; Spencer K; Kagan K K; Tørring N; Petersen OB; Christou A; Kallikas J; Nicolaides KH
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):404-11. PubMed ID: 20658511
[TBL] [Abstract][Full Text] [Related]
39. Early first-trimester free beta-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins.
Linskens IH; Spreeuwenberg MD; Blankenstein MA; van Vugt JM
Prenat Diagn; 2009 Jan; 29(1):74-8. PubMed ID: 19173346
[TBL] [Abstract][Full Text] [Related]
40. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
